ExploreWatchlistsPricing
  1. JP-listed companies
  2. 3-D Matrix,Ltd.
  3. Financials
  4. Cost of revenue

3-D Matrix,Ltd. (7777)

Market cap
¥55B
P/E ratio
59.5x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Apr 30, 20252,510+67.03%
Apr 30, 20241,502+46.46%
Apr 30, 20231,026+21.37%
Apr 30, 2022845+17.48%
Apr 30, 2021719+28.38%
Apr 30, 2020560+79.54%
Apr 30, 2019312+76.15%
Apr 30, 2018177+74.54%
Apr 30, 2017102-15.49%
Apr 30, 2016120+7676.31%
Apr 30, 20152

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat